He discovered the mechanisms behind SLE at an early stage – Uppsala University
… Rheumatology. Photo: Mikael Wallerstedt. Lars Rönnblom has spent much of his professional life studying the mechanisms behind the autoimmune …
Google News
RheumNow
Challenges diagnosing lung disease and ILD in pediatric patients
Challenges diagnosing lung disease and ILD in pediatric patients khoughton@cw.bc.ca Tue, 09/30/2025 – 08:00
PubMed
Analysis of Retracted Publications on Methotrexate
J Korean Med Sci. 2025 Sep 29;40(38):e243. doi: 10.3346/jkms.2025.40.e243. ABSTRACT BACKGROUND: Methotrexate (MTX) is a frequently used antifolate agent in
PubMed
Advanced cardiovascular imaging in immune-mediated inflammatory diseases: redefining ischemic heart disease risk
Curr Opin Cardiol. 2025 Nov 1;40(6):424-431. doi: 10.1097/HCO.0000000000001254. Epub 2025 Sep 24. ABSTRACT PURPOSE OF REVIEW: Immune-mediated inflammatory diseases (IMIDs)
PubMed
Intermittent fasting triggers interorgan communication to improve the progression of diabetic osteoporosis
Gut Microbes. 2025 Dec;17(1):2555619. doi: 10.1080/19490976.2025.2555619. Epub 2025 Sep 30. ABSTRACT Diabetic osteoporosis is a disease that seriously affects health,
PubMed
The diagnostic utility of miRNA21 in systemic sclerosis
Reumatismo. 2025 Sep 25. doi: 10.4081/reumatismo.2025.1773. Online ahead of print. ABSTRACT OBJECTIVE: Systemic sclerosis (SSc) is a multisystem autoimmune disease
PubMed
ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine
Diabetes Obes Metab. 2025 Sep 30. doi: 10.1111/dom.70167. Online ahead of print. ABSTRACT AIMS: This study evaluated the metabolic efficacy
PubMed
The Calcium Conundrum: Hypercalcemia of Unknown Etiology
Cureus. 2025 Aug 28;17(8):e91200. doi: 10.7759/cureus.91200. eCollection 2025 Aug. ABSTRACT Hypercalcemia is a common clinical finding with a wide variety
PubMed
Experience with Use of Rituximab in Different Connective Tissue Diseases in Bangladesh
Mymensingh Med J. 2025 Oct;34(4):1221-1230. ABSTRACT Aim of the study was to assess the tolerance and efficacy of rituximab in
PubMed
Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol
Trials. 2025 Sep 29;26(1):376. doi: 10.1186/s13063-025-09063-7. ABSTRACT BACKGROUND: The importance of self-management strategies that optimise physical health and mental health
PubMed
Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial
Trials. 2025 Sep 29;26(1):381. doi: 10.1186/s13063-025-09015-1. ABSTRACT BACKGROUND: Rheumatoid arthritis (RA) impacts quality of life causing disability and increased mortality.
PubMed
Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease
Arthritis Res Ther. 2025 Sep 29;27(1):184. doi: 10.1186/s13075-025-03656-y. ABSTRACT BACKGROUND: Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is difficult to manage
PubMed
KDM6B promotes ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes via the miR-128-3p/SLC7A11 axis through H3K27me3 modification
J Orthop Surg Res. 2025 Sep 29;20(1):862. doi: 10.1186/s13018-025-06277-y. ABSTRACT BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease,
PubMed
Childhood-onset Takayasu arteritis: clinical presentation, challenges and disease course
Pediatr Rheumatol Online J. 2025 Sep 29;23(1):94. doi: 10.1186/s12969-025-01147-7. ABSTRACT BACKGROUND: Takayasu arteritis (TAK) is a rare granulomatous inflammatory vasculitis
PubMed
Observational studies of early versus late salvage therapies in critical care exhibit intrinsic selection bias: two meta-analyses
Crit Care. 2025 Sep 29;29(1):411. doi: 10.1186/s13054-025-05663-6. ABSTRACT BACKGROUND: It is difficult to determine the optimal timing of salvage therapies,
PubMed
Defining the strategies to advance health-literacy-friendly patient decision aids based on the ICA-NRM approach
BMC Health Serv Res. 2025 Sep 29;25(1):1218. doi: 10.1186/s12913-025-13439-5. ABSTRACT BACKGROUND: Patient decision aids (PtDAs) are evidence-based tools that guide
Rheumatology
Physicians ‘have not invested enough time’ to understand taxes
CHICAGO — As physicians increasingly find themselves working as employees rather than owners, understanding tax structures and preserving their income
Wiley
Granulomatosis with polyangiitis presenting as strawberry gingivitis: methodologic aspects: comment on the article by Liu et al
Arthritis &Rheumatology, Volume 77, Issue 10, Page 1454-1454, October 2025.
JCR
Knowledge and Behaviors in Reproductive Health Among Mexican Women With Autoimmune Rheumatic Diseases: Cross-sectional Study
Background: Reproductive health is a critical issue for women with autoimmune rheumatic diseases (ARDs), yet significant gaps in knowledge and
JCR
A Novel Scoring System for Diagnosing Systemic Lupus Erythematosus–Related Cytopenias: Insights From a Cohort Study
Objective: To develop a score for a diagnosis of cytopenias from systemic lupus erythematosus (SLE) activity and determine the usefulness
JCR
The Number of Affected Joints Is Still a Distinguishing Criterion for Classifying Patients With Juvenile Idiopathic Arthritis
Objective: Juvenile idiopathic arthritis is a heterogeneous group of chronic childhood arthritis. We planned to classify patients with oligoarticular, rheumatoid
JCR
Comparison of Cardiovascular Risk Scores Performances in a Contemporary Mixed-Ancestry Systemic Lupus Erythematosus Population
Objective: Cardiovascular disease (CVD) remains the leading cause of mortality in systemic lupus erythematosus (SLE). This study compared the performance
JCR
Global Guidelines for Psoriatic Arthritis Management: A Comparative Analysis
Background: Psoriatic arthritis (PsA) is a complex immune-mediated heterogeneous inflammatory disease. Treatment decisions are challenging given the multisystem involvement. To
JCR
Clinical Characteristics of Antinuclear Antibody–Negative Systemic Lupus Erythematosus: A Systematic Review
Although antinuclear antibody (ANA) positivity on HEp-2 cells is a mandatory criterion for the classification of systemic lupus erythematosus (SLE),
JCR
Management Practices for Raynaud Phenomenon in Patients With Systemic Sclerosis: A Real-World Data From Community-Based Practices in the United States
Objective: To describe Raynaud phenomenon (RP) management practices for systemic sclerosis (SSc) patients among US community-based rheumatologists. Methods: We identified
JCR
Therapeutic Choices in Systemic Sclerosis–Associated Interstitial Lung Disease, a Survey of 2 International Research Groups
Background: Options for systemic sclerosis–associated interstitial lung disease (SSc-ILD) have evolved rapidly. Mycophenolate mofetil (MMF) has replaced cyclophosphamide (CYC) in
JCR
Increasing Biosimilar Uptake in Rheumatology Clinics Within a Large Academic Medical Center
Objective: Biological drugs have revolutionized the treatment of rheumatic diseases, but their high cost has contributed to increased prescription drug